High throughput sequencing
in molecular biology
In oncology, molecular tests are already essential, and will be even more so in the future as targeted therapies increase in scope and precision. As a member of the Cerba HealthCare group, the teams at Cerba Path work in close collaboration with colleagues at the Cerba laboratory, French leader in molecular biology. Any sample entrusted by a clinician to Cerba Path is eligible for Next Generation Sequencing (NGS) at one of Cerba’s nine sequencers, an option that opens up the possibility for the simultaneous analysis of a very large number of genes.